Document is current
Any future updates will be listed below
-
Authors
Rustamov, Nabi
Demarest, Phillip
Han, Zhuangyu
Mohamud, Safia
Haroutounian, Simon
Leuthardt, Eric C.
- License Information
-
More Information
Article History
Received: 16 February 2025
Accepted: 4 August 2025
First Online: 14 August 2025
Declarations
:
: ECL has stock ownership in Neurolutions, Inner Cosmos, Aurenar, and Sora Neuroscience. Washington University also owns stock in Neurolutions. This work and E.C. Leuthardt have had their conflict of interest rigorously evaluated and managed throughout this study and with creation of this manuscript. SH has received consultancy fees from Vertex and research funding from Eli Lilly, unrelated to the presented work. The remaining authors have no conflicts of interest to declare.
: This study was approved by the institutional review board of Washington University School of Medicine in St. Louis. All experimental procedures conformed to the standards set by the latest revision of the Declaration of Helsinki. All participants provided written informed consent before participation in the study.
